The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2016

Filed:

Sep. 21, 2012
Applicant:

Texas a & M University System, College Station, TX (US);

Inventors:

Robert Y. Tsai, Pearland, TX (US);

Tao Lin, Houston, TX (US);

Assignee:

THE TEXAS A&M UNIVERSITY SYSTEM, College Station, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/365 (2006.01); A61K 38/14 (2006.01); A61K 45/06 (2006.01); A61K 31/203 (2006.01); A61K 31/337 (2006.01); A61K 31/4745 (2006.01); A61K 31/513 (2006.01); A61K 31/555 (2006.01); A61K 31/704 (2006.01); A61K 31/7048 (2006.01); A61K 31/282 (2006.01);
U.S. Cl.
CPC ...
A61K 31/365 (2013.01); A61K 31/203 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/4745 (2013.01); A61K 31/513 (2013.01); A61K 31/555 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 38/14 (2013.01); A61K 45/06 (2013.01);
Abstract

In some embodiments, the present invention provides methods of treating a tumor in a subject. In some embodiments, the methods may include a step of administering to the subject a therapeutic composition that comprises: (a) mycophenolic acid, an analog thereof, or a derivative thereof; and (b) at least one anti-neoplastic agent. In some embodiments, the antineoplastic agent may include at least one of 5-fluouracil (5-FU), paclitaxel, oxaliplatin, doxorubicin, etoposide, irinotecan, bleomycin, imiquimod, 13-cis-retinoic acid, and combinations thereof. In some embodiments, the relative concentrations of the mycophenolic acid, the analog thereof, or the derivative thereof, and the at least one anti-neoplastic agent correspond to their respective IC50 values. In some embodiments, the methods of the present invention may be used to treat tumors associated with at least one of an oral cancer, a skin cancer, a breast cancer, a prostate cancer, precancerous lesions thereof, hyperplastic lesions thereof, and benign tumors thereof.


Find Patent Forward Citations

Tsai, Robert. (2016). Mycophenolic acid analogues as anti-tumor chemosensitizing agents (U.S. Patent No. 9492426). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9492426

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…